Searched for
SANDOZ AG
Stocks in news: Maruti Suzuki, Tata Steel, Varun Beverages, PNB, TCSMarkets saw a second consecutive day of recovery, driven by value buying and stable global cues, with analysts expecting a rebound towards ...- Strides Pharma to acquire Sandoz branded generics portfolio to expand Africa businessStrides Pharma Science is preparing to enhance its presence in Sub-Saharan Africa by acquiring branded generic products from Sandoz AG, wit...
- Lupin ties up with Sandoz to commercialise biosimilar productLupin has partnered with Sandoz Group AG to commercialize its biosimilar ranibizumab across multiple regions, with Sandoz handling commerci...
- Trump’s $1.4 trillion tariff threat spurs companies to seek coverCompanies like Novo Nordisk, Boeing, and Walmart are preparing for the impacts of President Donald Trump’s tariffs. Executives are assessin...
- Swiss chemical company Clariant AG forms JV with India GlycolsAs per the terms of the agreement, India Glycols will contribute its renewable Bio-EO derivative business to the JV, which includes a multi...
- Novartis scraps sale of assets including COVID-19 hopeful to India's AurobindoNovartis AG on Thursday scrapped the $1 billion sale of U.S. generic pill and skin drug assets to India's Aurobindo Pharma Ltd as regulator...
- Buy Aurobindo Pharma, target Rs 836: Elara CapitalBuy Aurobindo Pharma Ltd. at a price target of Rs 836.
- KPMG appoints Ajaz Hussain as senior advisorAjaz Hussain is currently serving as the President of The National Institute for Pharmaceutical Technology and Education, a not-for-profit ...
- Sun Pharma gets boost with US FDA approval for GleevecSun Pharmaceutical announced it received approval from the US FDA for generic copies of Gleevec, a drug that treats chronic myeloid leukemi...
- Novartis gets USFDA warning letter for two plants in IndiaSandoz, the generic drug arm of Swiss drug major Novartis, has received a warning letter from the US health regulator for violations of cur...
- US court finds Teva's Copaxone patent invalid again: Natco PharmaNatco Pharma, a city-based drug maker, today said the US Court of Appeals for Federal Court has again found one of the patents of Teva's Co...
- Natco slumps; US court rules for Teva in drug patent caseUS Supreme Court sends patent case back to lower court. Generic launches by Natco and other pharma companies will be delayed, say analysts.
- Natco Pharma cracks 19% as US justices agrees to hear Teva's Copaxone appealThe decision by the Supreme Court comes at a time when Teva is switching its daily version of Copaxone to twice a week version.
- Drugs pricing row: 7 pharmaceutical companies move HC against Centre's orderSeven more pharmaceutical companies including Novartis India Limited today moved the Delhi High Court to challenge the government's new dru...
- Novartis says Q1 profit up 49 pcDrug maker Novartis AG said on Tuesday that strong sales particularly of swine flu vaccine helped increase net profit by 49 per cent to $2....
- Novartis buys part of generics maker for $1.2 bnSwiss pharmaceuticals giant Novartis AG will buy the generic injectable cancer drugs business of Austria's EBEWE Pharma for euro925 million...
- Retailers end boycott of NovartisOver 7,000 retailers and stockists had stopped selling all the 198 medicines of two firms from April 1, protesting the drugmakers’ practice...
- Novartis posts 7% rise in Q1 net profitPharmaceuticals maker Novartis AG reported a 7 percent rise in first-quarter net income on Monday on the back of a declining dollar and sol...
- Drugmakers may get EU tariff reliefThe European Union may trim import tariffs on Indian drugmakers including Ranbaxy Laboratories because of evidence that subsidies fell, a s...
- Cipla, PEs team up for Merck's bizRanbaxy Lab, Teva Corp, Actavis and Mylan are among the cos short listed in the first round.
Load More
